VEGFR2/CD309 anticorps (Extracellular Domain)
Aperçu rapide pour VEGFR2/CD309 anticorps (Extracellular Domain) (ABIN1493515)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- Extracellular Domain
-
Specificité
- Human. No cross reactivity with other proteins.
-
Réactivité croisée (Details)
- No cross reactivity with other proteins.
-
Purification
- Affinity purified
-
Immunogène
-
Recombinant human extracellular domain of VEGFR-2 (KDR).
Type of Immunogen: Recombinant protein -
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- 1.2 % sodium acetate or neutral PBS.
-
Concentration
- Lot specific
-
Buffer
- 1.2 % sodium acetate, 2 mg BSA, 0.01 mg sodium azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Short term: 4°C
Long term: -20°C.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- KDR / VEGFR2
-
Sujet
-
Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2 -
ID gène
- 3791
-
UniProt
- P35968
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-